Extension to Covid medicine PBS listing

Government announces a new demographic cohort will have PBS access to an anti-COVID medication The Federal government has announced that, from 1 July, the eligibility criteria for PBS access to Paxlovid (nirmatrelvir and ritonavir) will expand to include people aged 50-59 years of age with mild to moderate COVID-19, and with one additional risk factor